Abstract
Specific peptides derived from the cytotoxicity receptor natural killer protein 44 (NKp44) useful for treating diseases such as cancer are described. The invention further relates to compositions comprising a fragment of the extracellular region of NKp44 for preventing or treating cancer.
| Original language | English |
|---|---|
| Patent number | US9399667B2 |
| State | Published - 1 Jul 2016 |
Fingerprint
Dive into the research topics of 'Peptides derived from cytotoxicity receptor natural killer protein 44 NKP44'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver